Acquisitions and Divestitures - Discontinued Operations - Net of Tax (Detail) (USD $) In Millions, unless otherwise specified	3 Months Ended				9 Months Ended
	Sep. 30, 2012		Oct. 02, 2011		Sep. 30, 2012		Oct. 02, 2011
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Revenues	$ 564	[1]	$ 699	[1]	$ 1,665	[1]	$ 2,068	[1]
Pre-tax income from discontinued operations	129		121		365		397
Provision for taxes on income	25	[2]	25	[2]	116	[2]	94	[2]
Income from discontinued operations––net of tax	104		96		249		303
Pre-tax gain on sale of discontinued operations	0		1,695		0		1,683
Provision for taxes on income	0	[3]	367	[3]	0	[3]	367	[3]
Gain on sale of discontinued operations––net of tax	0		1,328		0		1,316
Discontinued operations-net of tax	$ 104		$ 1,424		$ 249		$ 1,619

[1] Includes the Nutrition business for all periods presented and the Capsugel business for 2011 only.

[2] Includes deferred tax expense of $9 million and a deferred tax benefit of $10 million for the three months ended September 30, 2012 and October 2, 2011, respectively, and a deferred tax expense of $23 million and a deferred tax benefit of $17 million for the nine months ended September 30, 2012 and October 2, 2011, respectively. These deferred tax provisions include deferred income taxes related to investments in certain foreign subsidiaries resulting from our intention not to hold these subsidiaries permanently.

[3] Includes deferred tax expense of $162 million for the three and nine months ended October 2, 2011. These deferred tax provisions include deferred taxes on certain current-year funds earned outside the U.S. that will not be permanently reinvested overseas.